Skip to main content
Unchecking box will stop auto data updates
Delayed Price USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 0.4500
Day High 0.5393
Open:0.5393
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Marina Biotech, Inc., formerly known as MDRNA, Inc., is a biotechnology company, focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The Company's pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs in hepatocellular carcinoma and bladder cancer. Marina's goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Marina Biotech, Inc. is headquartered in Bothell, Washington.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Marina Biotech Announces Name Change to Adhera Therapeutics to More Closely Reflect the Mission of Improving Patient Outcomes
GlobeNewswire - Tue Oct 9, 7:00AM CDT
GlobeNewswire - CMTX
Tue Oct 9, 7:00AM CDT
Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis and pain, today announced that it has changed its name to Adhera Therapeutics, Inc. and that it will begin using the ticker ATRX, in each case effective October 9, 2018. This new name reflects the company's mission to develop and commercialize unique pharmaceutical therapies and leverage technology to improve patient outcomes.
Marina Biotech Appoints Nancy R. Phelan to the Board of Directors
GlobeNewswire - Wed Oct 3, 7:04AM CDT
GlobeNewswire - CMTX
Wed Oct 3, 7:04AM CDT
Research Triangle Park, NC, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis and pain, today announced that Nancy R. Phelan has been appointed to serve as a member of its Board of Directors, effective today.
Marina Biotech Appoints Eric Teague as Chief Financial Officer
GlobeNewswire - Mon Sep 24, 7:00AM CDT
GlobeNewswire - CMTX
Mon Sep 24, 7:00AM CDT
Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis, pain and oncology, today announced the appointment of Eric Teague as Chief Financial Officer of the Company.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.4000 +12.50% increase
on 10/02/18
Period Open:0.5500
Price movement based on the high, low and last over the given period.
0.7000 -35.71% decrease
on 09/18/18
-0.1000 (-18.18%) decrease
since 09/07/18
3-Month 0.4000 +12.50% increase
on 10/02/18
Period Open:0.6600
Price movement based on the high, low and last over the given period.
0.8000 -43.75% decrease
on 08/31/18
-0.2100 (-31.82%) decrease
since 07/06/18
52-Week 0.4000 +12.50% increase
on 10/02/18
Period Open:2.4000
Price movement based on the high, low and last over the given period.
2.4000 -81.25% decrease
on 10/18/17
-1.9500 (-81.25%) decrease
since 10/06/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement